Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Bromodeoxyuridine

"Bromodeoxyuridine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors.


This graph shows the total number of publications written about "Bromodeoxyuridine" by people in Harvard Catalyst Profiles by year, and whether "Bromodeoxyuridine" was a major or minor topic of these publication.
Bar chart showing 252 publications over 30 distinct years, with a maximum of 23 publications in 2007
To see the data from this visualization as text, click here.
Related Networks
People
Explore
_
Similar Concepts
_
Top Journals 
_
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.